Inhibrx GAAP EPS -2.34 misses by 0.06; interest expense rises
Inhibrx reports GAAP EPS of -2.34, missing by 0.06, while interest expense jumps to $4.5M from $1.3M amid debt rising to $175M from $100M.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.